Reply to Letter to the Editor: "Psychedelics in Older Adults: Difficulties of a Clear Therapeutic Evidence".
Hannes Kettner, Leor Roseman, Adam Gazzaley, Robin L. Carhart-Harris, Lorenzo Pasquini
Am J Geriatr Psychiatry September 26, 2024 DOI: 10.1016/j.jagp.2024.09.009 via PubMed
Summary
AI-generated from the abstractA reply to a letter to the editor addresses difficulties in establishing clear therapeutic evidence for psychedelics in older adults. The response likely discusses challenges such as study design, sample size, and confounding factors that complicate the interpretation of clinical data on psychedelic treatments for this population. It emphasizes the need for rigorous research to clarify the potential benefits and risks of psychedelic therapy in geriatric mental health care.
Study at a glance
| Characteristics | Reply to letter to the editor Peer reviewed |
|---|---|
| Keywords | Psychedelics Psychedelic drugs Hallucinogens Entheogens Older adults |
| Key finding | Establishing clear therapeutic evidence for psychedelics in older adults faces difficulties related to study design and confounding factors. |
Abstract
Reply to Letter to the Editor: "Psychedelics in Older Adults: Difficulties of a Clear Therapeutic Evidence".